Kenalog Topical Spray, Solution 0.147Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Kenalog: Topical spray, solution (0.147mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Kenalog 0.147mg/g Top Spray
Drug Image file default-drug-image.png
Kenalog 0.147mg/g Top Spray

What is this Medicine?

TRIAMCINOLONE (trye am SIN oh lone) is a corticosteroid. It is used on the skin to reduce swelling, redness, itching, and allergic reactions.

CVS Pharmacy Patient Statistics for Kenalog: Topical spray, solution(0.147mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Kenalog 0.147mg/g Topical Spray

NDC: 106310093
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Alopecia, Pruritus, Contact Dermatitis, Discoid Lupus Erythematosus, Eczema, Keloids, Rhus Dermatitis, Xerosis, Insect Bites Or Stings, Sarcoidosis, Seborrheic Dermatitis, Pemphigus, Atopic Dermatitis, Lichen Planus, Granuloma Annulare, Lichen Simplex, Psoriasis, Lichen Striatus, Mycosis Fungoides, Exfoliative Dermatitis, Necrobiosis Lipoidica Diabeticorum

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Avoid excessive heat (above 104 degrees F)
Kenalog 0.147mg/g Topical Spray

Reported Side Effects for Kenalog 0.147mg/g Topical Spray

Visual Impairment Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Rash With Pustules Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Second Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Third Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Kenalog

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.